HomeCompareCI vs NKE

CI vs NKE: Dividend Comparison 2026

CI yields 2.36% · NKE yields 3.16%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CI wins by $131.63M in total portfolio value· pulled ahead in Year 2
10 years
CI
CI
● Live price
2.36%
Share price
$258.08
Annual div
$6.09
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$133.48M
Annual income
$123,432,595.24
Full CI calculator →
NKE
NKE
● Live price
3.16%
Share price
$51.24
Annual div
$1.62
5Y div CAGR
66.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.85M
Annual income
$1,337,341.87
Full NKE calculator →

Portfolio growth — CI vs NKE

📍 CI pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCINKE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CI + NKE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CI pays
NKE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CI
Annual income on $10K today (after 15% tax)
$200.58/yr
After 10yr DRIP, annual income (after tax)
$104,917,705.95/yr
NKE
Annual income on $10K today (after 15% tax)
$268.74/yr
After 10yr DRIP, annual income (after tax)
$1,136,740.59/yr
At 15% tax rate, CI beats the other by $103,780,965.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CI + NKE for your $10,000?

CI: 50%NKE: 50%
100% NKE50/50100% CI
Portfolio after 10yr
$67.67M
Annual income
$62,384,968.55/yr
Blended yield
92.19%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NKE right now

CI
Analyst Ratings
1
Strong
31
Buy
7
Hold
Consensus: Buy
Price Target
$325.83
+26.3% upside vs current
Range: $300.00 — $375.00
Altman Z
2.7
Piotroski
7/9
NKE
Analyst Ratings
1
Strong
42
Buy
23
Hold
4
Sell
Consensus: Buy
Price Target
$75.35
+47.1% upside vs current
Range: $62.00 — $110.00
Altman Z
3.8
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CI buys
9
NKE buys
0
PoliticianChamberTickerTypeAmountDate
Julie Johnson🏢 House$CI▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$CI▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$CI▼ Sell$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$CI▼ Sell$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$CI▼ Sell$1,001 - $15,0002025-09-29
Julie Johnson🏢 House$CI▼ Sell$1,001 - $15,0002025-09-25
Ro Khanna🏢 House$CI▲ Buy$1,001 - $15,0002025-09-05
Julie Johnson🏢 House$CI▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$CI▼ Sell$1,001 - $15,0002025-08-05
Jared Moskowitz🏢 House$CI▲ Buy$1,001 - $15,0002025-05-15
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCINKE
Forward yield2.36%3.16%
Annual dividend / share$6.09$1.62
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%66.3%
Portfolio after 10y$133.48M$1.85M
Annual income after 10y$123,432,595.24$1,337,341.87
Total dividends collected$132.70M$1.78M
Payment frequencyquarterlyquarterly
SectorHealthcareConsumer Discretionary
Analyst consensusBuyBuy
Analyst price target$325.83$75.35

Year-by-year: CI vs NKE ($10,000, DRIP)

YearCI PortfolioCI Income/yrNKE PortfolioNKE Income/yrGap
1$11,172$471.95$11,226$525.77$54.00NKE
2← crossover$12,940$985.53$12,929$917.32+$11.00CI
3$15,979$2,133.55$15,476$1,642.01+$503.00CI
4$22,022$4,924.66$19,614$3,054.78+$2.4KCI
5$36,250$12,686.29$27,004$6,017.26+$9.2KCI
6$77,820$39,032.84$41,770$12,875.77+$36.0KCI
7$239,893$156,625.47$75,648$30,954.02+$164.2KCI
8$1,159,158$902,472.79$168,071$87,127.77+$991.1KCI
9$9,391,197$8,150,897.78$480,693$300,856.83+$8.91MCI
10$133,481,176$123,432,595.24$1,851,684$1,337,341.87+$131.63MCI

CI vs NKE: Complete Analysis 2026

CIHealthcare

The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Full CI Calculator →

NKEConsumer Discretionary

NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells men's, women's, and kids athletic footwear, apparel, equipment, and accessories worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks. In addition, it sells a line of performance equipment and accessories comprising bags, socks, sport balls, eyewear, timepieces, digital devices, bats, gloves, protective equipment, and other equipment for sports activities under the NIKE brand; and various plastic products to other manufacturers. The company markets apparel with licensed college and professional team, and league logos, as well as sells sports apparel. Additionally, it licenses unaffiliated parties to manufacture and sell apparel, digital devices, and applications and other equipment for sports activities under NIKE-owned trademarks. The company sells its products to footwear stores; sporting goods stores; athletic specialty stores; department stores; skate, tennis, and golf shops; and other retail accounts through NIKE-owned retail stores, digital platforms, independent distributors, licensees, and sales representatives. The company was formerly known as Blue Ribbon Sports, Inc. and changed its name to NIKE, Inc. in 1971. NIKE, Inc. was founded in 1964 and is headquartered in Beaverton, Oregon.

Full NKE Calculator →
📬

Get this CI vs NKE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CI vs SCHDCI vs JEPICI vs OCI vs KOCI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.